Species associated with infection - S. mucilaginosus (previously Micrococcus sp.)
Associated infections - endocarditis, meningitis, neutropenic sepsis
Reported susceptibilities and therapies - glycopeptides, imipenem, rifampicin, ceftriaxone
References - von Eiff, C., Peter,s G.(1998). In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients. Eur. J. clin. Microbiol. infect. Dis. 17, 890-892. - Condron, P.E., Markowitz, S.M., Moharty, L.B., Schatzki, P.F., Payne, J.M. (1987). Isolation of Stomatococcus mucilaginosus from drug user with endocarditis. J. clin. Microbiol. 25, 1359-1363. - 421. Gruson, D., Hilbert, G., Pigneux, A., Vargas, F., Guisset, O., Texier, J., Boiron, J.M., Reiffers, J., Gbikpi-Benissan, G., Cardinaud, J.P. (1998). Severe infection caused by Stomatococcus mucilaginosus in a neutropenic patient: case report and review of the literature. Hematol. Cell. Ther. 40, 167-169. - Park, M.K., Khan, J., Stock, F., Lucey, D.R. (1997). Successful treatment of Stomatococcus mucilaginosus meningitis with intravenous vancomycin and intravenous ceftriaxone. Clin. infect. Dis. 24, 278.
